<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HCD955382D1494A4CA95B27B6D28FC895" public-private="public" bill-type="olc"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 2730 IH: National Prostate Cancer Plan Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-06-11</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code> 
<congress>114th CONGRESS</congress>
<session>1st Session</session>
<legis-num>H. R. 2730</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20150611">June 11, 2015</action-date> 
<action-desc><sponsor name-id="B001251">Mr. Butterfield</sponsor> (for himself, <cosponsor name-id="M001157">Mr. McCaul</cosponsor>, <cosponsor name-id="C000984">Mr. Cummings</cosponsor>, and <cosponsor name-id="J000255">Mr. Jones</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc>
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To establish the National Prostate Cancer Council for improved screening, early detection, assessment, and monitoring of prostate cancer, and to direct the development and implementation of a national strategic plan to expedite advancement of diagnostic tools and the transfer of such tools to patients.</official-title> 
</form> 
<legis-body id="HD49FB1A49A0F44EC883D4B375B4D6E45" style="OLC"> 
<section id="H8A26EB4E56E146DC96EC8094CC53C97C" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>National Prostate Cancer Plan Act</short-title></quote>.</text></section> <section id="HBD8B2344BE2E47FC8E539BFDADA46A55"><enum>2.</enum><header>National prostate cancer council</header> <subsection id="H2B4BB77DBFC94A13A6E23C4D42290210"><enum>(a)</enum><header>Establishment</header><text>There is established in the Office of the Secretary of Health and Human Services (referred to in this section as the <quote>Secretary</quote>) the National Prostate Cancer Council on Screening, Early Detection, Assessment, and Monitoring of Prostate Cancer (referred to in this Act as the <quote>Council</quote>).</text></subsection> 
<subsection id="H62CBBF226C4A493B9C36242E16B1E433"><enum>(b)</enum><header>Purpose of the council</header><text>The Council shall—</text> <paragraph id="HD6F4ECF667BC4F04853ECCFB43B67848"><enum>(1)</enum><text>develop and implement a national strategic plan for the accelerated creation, advancement, and testing of diagnostic tools to improve screening, early detection, assessment, and monitoring of prostate cancer, including—</text> 
<subparagraph id="H19D1781B9F524E5DB982459A7BE9B94B"><enum>(A)</enum><text>early detection of aggressive prostate cancer to save lives;</text></subparagraph> <subparagraph id="HB8B85A59F65A476A9F56B5DDC9A61B59"><enum>(B)</enum><text>monitoring of tumor response to treatment, including recurrence and progression; and</text></subparagraph> 
<subparagraph id="HAD942D5216B945AA90481842A09CEF78"><enum>(C)</enum><text>accurate assessment and surveillance of indolent disease to reduce unnecessary biopsies and treatment;</text></subparagraph></paragraph> <paragraph id="HBAD9AD93A3A848ECA5736AF573C0E22C"><enum>(2)</enum><text>provide information and coordination of prostate cancer research and services across all Federal agencies;</text></paragraph> 
<paragraph id="HAE6BEC95B1DB4EE4A0E66A1B6AF4222D"><enum>(3)</enum><text>review diagnostic tools and their overall effectiveness at screening, detecting, assessing, and monitoring of prostate cancer;</text></paragraph> <paragraph id="H9A12004D815543F2BE8BF05E9F3BA558"><enum>(4)</enum><text>evaluate all programs in prostate cancer that are in existence on the date of enactment of this Act, including Federal budget requests and approvals and public-private partnerships;</text></paragraph> 
<paragraph id="HDE9A4832209D482DBF01287F281C768A"><enum>(5)</enum><text>submit an annual report to the Secretary and Congress on the creation and implementation of the national strategic plan under paragraph (1); and</text></paragraph> <paragraph id="HB499CFAE01F9486BB501C2EDBC381C03"><enum>(6)</enum><text>ensure the inclusion of men at high-risk for prostate cancer, including men from ethnic and racial populations and men who are least likely to receive care, in clinical, research, and service efforts, with the purpose of decreasing health disparities.</text></paragraph></subsection> 
<subsection id="H7C9DCC4264EC417A97070DEA94FD06FC"><enum>(c)</enum><header>Membership</header> 
<paragraph id="HCF9C173BBFF049E8B248CF05C961D127"><enum>(1)</enum><header>Federal members</header><text>The Council shall be led by the Secretary or designee and comprised of the following experts:</text> <subparagraph id="H299C14AB6A2943E0906B88ACA6D71CB7"><enum>(A)</enum><text>Two representatives of the National Institutes of Health, including 1 representative of the National Institute of Biomedical Imaging and Bioengineering and 1 representative of the National Cancer Institute.</text></subparagraph> 
<subparagraph id="HDB3CF89E6FC14116B9312F821AC6C4D0"><enum>(B)</enum><text>A representative of the Centers for Disease Control and Prevention.</text></subparagraph> <subparagraph id="H71B5C1D032E94D8AB481F95CD8459BEE"><enum>(C)</enum><text>A representative of the Centers for Medicare and Medicaid Services.</text></subparagraph> 
<subparagraph id="HA67302089AA94C988EB8232B6FF5F34C"><enum>(D)</enum><text>A designee of the Director of the Department of Defense Congressionally Directed Medical Research Program.</text></subparagraph> <subparagraph id="H38E198E6A0464C54B1A2B45C3A42E84F"><enum>(E)</enum><text>A designee of the Director of the Office of Minority Health.</text></subparagraph> 
<subparagraph id="HFD67853563D04B69A285022C564E798C"><enum>(F)</enum><text>A representative of the Food and Drug Administration.</text></subparagraph> <subparagraph id="H230ED28F68EA41179FE5C050A3895FDE"><enum>(G)</enum><text>A representative of the Agency for Healthcare Research and Quality.</text></subparagraph></paragraph> 
<paragraph id="HAA568B5ACAF6464EA36FA8E374FA0982"><enum>(2)</enum><header>Non-federal members</header><text>In addition to the members described in paragraph (1), the Council shall include 14 expert members from outside the Federal Government, which shall include—</text> <subparagraph id="HFEAD29B853F84670BA367016A2779EDD"><enum>(A)</enum><text>6 prostate cancer patient advocates, including—</text> 
<clause id="H87ECB097769B48019E1CD2DC104F2E69"><enum>(i)</enum><text>2 patient-survivors;</text></clause> <clause id="H2855374B415743FC944D35F67B4EF5FF"><enum>(ii)</enum><text>2 caregivers of prostate cancer patients; and</text></clause> 
<clause id="H58D354FE14C04162BC03CFD09CDC11BD"><enum>(iii)</enum><text>2 representatives from national prostate cancer disease organizations that fund research or have demonstrated experience in providing assistance to patients, families, and medical professionals, including information on health care options, education, and referral; and</text></clause></subparagraph> <subparagraph id="H6F9BE91B539743F6A02940D9FA3ACF04"><enum>(B)</enum><text>8 health care stakeholders with specific expertise in prostate cancer research in the critical areas of clinical expertise, including medical oncology, radiology, radiation oncology, urology, and pathology.</text></subparagraph></paragraph></subsection> 
<subsection id="H3DB4393913E14E2792230560D517BCEA"><enum>(d)</enum><header>Meetings</header><text>The Council shall meet quarterly and meetings shall be open to the public.</text></subsection> <subsection id="H1D200AD9BE014D3AA6E8F4354FD986E2"><enum>(e)</enum><header>Advice</header><text>The Council shall advise the Secretary, or the Secretary’s designee.</text></subsection> 
<subsection id="H2103C1F376DE4AA4ACA507194116C816"><enum>(f)</enum><header>Annual report</header><text>The Council shall submit annual reports, beginning not later than 1 year after the date of enactment of this Act, to the Secretary or the Secretary’s designee and to Congress. The annual report shall include—</text> <paragraph id="H5F776EC585634F909AFEFDB241FAF411"><enum>(1)</enum><text>in the first year—</text> 
<subparagraph id="H41EDAC66ACB8403D9C904AF1E1897DFF"><enum>(A)</enum><text>an evaluation of all federally funded efforts in prostate cancer research and gaps relating to the development and validation of diagnostic tools for prostate cancer; and</text></subparagraph> <subparagraph id="H882612E6E8ED4FE48AAA5E7C035E22A2"><enum>(B)</enum><text>recommendations for priority actions to expand, eliminate, coordinate, or condense programs based on the performance, mission, and purpose of the programs; and</text></subparagraph></paragraph> 
<paragraph id="H8F403F757C54480AAB5740627838C95A"><enum>(2)</enum><text>annually thereafter for 5 years—</text> <subparagraph id="H218150EC6CB84F089A5C5CBE6FBCA804"><enum>(A)</enum><text>an outline for the development and implementation of a national research plan for creation and validation of accurate diagnostic tools to improve prostate cancer care in accordance with subsection (a);</text></subparagraph> 
<subparagraph id="HC57B016DC7A048CEB039A9D612176B67"><enum>(B)</enum><text>roles for the National Cancer Institute, National Institute on Minority Health and Health Disparities, and the Office on Minority Health of the Department of Health and Human Services;</text></subparagraph> <subparagraph id="H2830F5EB6FF5468A9A4EED3F23262014"><enum>(C)</enum><text>an analysis of the disparities in the incidence and mortality rates of prostate cancer in men at high risk of the disease, including individuals with family history, increasing age, or African-American heritage; and</text></subparagraph> 
<subparagraph id="HECFDAAE94A4144FCB41502281C4B71CA"><enum>(D)</enum><text>a review of the progress towards the realization of the proposed strategic plan.</text></subparagraph></paragraph></subsection> <subsection id="H52DFAA7786924D478F5E07559F1F3BC8"><enum>(g)</enum><header>Termination</header><text>The Council shall terminate on December 31, 2020.</text></subsection> </section> 
</legis-body> 
</bill> 

